National Cancer Institute: Exploring Hepatocellular Carcinoma

Opportunity ID: 44146

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-08-244
Funding Opportunity Title: Etiology, Prevention, and Treatment of Hepatocellular Carcinoma(R21)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.273 — Alcohol Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 05, 2008
Last Updated Date:
Original Closing Date for Applications: Sep 07, 2011
Current Closing Date for Applications: Sep 07, 2011
Archive Date: Oct 08, 2011
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Private institutions of higher education
Small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession; Units of Local Governments.

Additional Information

Agency Name: National Institutes of Health
Description: -Purpose. With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourage grant applications that: (a) address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC); (b) propose development of animal models for HCC; (c) propose novel approaches to prevent HCC malignancy; (d) propose therapeutic or diagnostic tools for reliable prognostic indicators for HCC; and/or (e) develop therapeutic approaches to minimize morbidity and mortality associated with HCC in humans. The primary focus of the proposed project must be on the basic biology, prevention, and/or treatment of liver cancer. Applications solely concerned with population studies and epidemiology will not be supported in connection with this FOA.
-Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with two FOAs of similar scientific scope: (1) PA-08-243, for research projects using the R01 mechanism; and (2) PAR-08-245, for program project grants under the P01 mechanism.
-Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-08-244.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-A Adobe-Forms-A PKG00009494 Dec 05, 2008 Feb 20, 2010 View
ADOBE-FORMS-B Use for submissions intended for due dates of January 25, 2010 and beyond PKG00015316 Dec 21, 2009 Oct 29, 2010 View
ADOBE-FORMS-B1 Supersedes ADOBE-FORMS-B PKG00022194 Oct 29, 2010 Sep 07, 2011 View

Package 1

Mandatory forms

44146 RR_SF424-1.1.pdf

44146 RR_KeyPersonExpanded-1.1.pdf

44146 RR_OtherProjectInfo-1.1.pdf

44146 RR_PerformanceSite-1.1.pdf

44146 PHS398_CoverPageSupplement-1.1.pdf

44146 PHS398_ResearchPlan-1.1.pdf

44146 PHS398_Checklist-1.1.pdf

Optional forms

44146 PHS398_CoverLetter-1.1.pdf

44146 PHS398_ModularBudget-1.1.pdf

44146 RR_Budget-1.1.pdf

44146 RR_SubawardBudget-1.2.pdf

Package 2

Mandatory forms

44146 RR_SF424_1_2-1.2.pdf

44146 PerformanceSite_1_3-1.3.pdf

44146 RR_OtherProjectInfo_1_2-1.2.pdf

44146 RR_KeyPersonExpanded_1_2-1.2.pdf

44146 PHS398_CoverPageSupplement_1_4-1.4.pdf

44146 PHS398_ResearchPlan_1_3-1.3.pdf

44146 PHS398_Checklist_1_3-1.3.pdf

Optional forms

44146 PHS_CoverLetter_1_2-1.2.pdf

44146 PHS398_ModularBudget-1.1.pdf

44146 RR_Budget-1.1.pdf

44146 RR_SubawardBudget-1.2.pdf

Package 3

Mandatory forms

44146 RR_SF424_1_2-1.2.pdf

44146 RR_OtherProjectInfo_1_3-1.3.pdf

44146 RR_KeyPersonExpanded_1_2-1.2.pdf

44146 PerformanceSite_1_4-1.4.pdf

44146 PHS398_ResearchPlan_1_3-1.3.pdf

44146 PHS398_CoverPageSupplement_1_4-1.4.pdf

44146 PHS398_Checklist_1_3-1.3.pdf

Optional forms

44146 RR_Budget-1.1.pdf

44146 RR_SubawardBudget-1.2.pdf

44146 PHS_CoverLetter_1_2-1.2.pdf

44146 PHS398_ModularBudget-1.1.pdf


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *